Status:
TERMINATED
Feasibility and Functionality of fPAM Imaging in Melanoma
Lead Sponsor:
Washington University School of Medicine
Conditions:
Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
Melanoma is a cutaneous malignancy that has the potential for local (skin) and regional (lymph node) recurrence. These recurrences may be difficult to detect in their earliest stages. We are attemptin...
Detailed Description
recruiting healthy individuals with pigmented lesions and individuals with melanoma and pigmented lesions
Eligibility Criteria
Inclusion
- Adult patients (\> 18 yrs of age) with recently diagnosed or a history of, Stage I - III melanoma who are able to give informed consent.
Exclusion
- Patients with melanomas \< 1mm.
- Pregnant females.
- Children and young adults \< 18 yrs of age and patients who are unable to give informed consent.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00776945
Start Date
January 1 2009
End Date
December 1 2014
Last Update
June 8 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
2
Washington University
St Louis, Missouri, United States, 63110